Overview
Single-board non-malignant hematology track supported by the ASH HFFTP, focusing on sickle cell disease, thrombosis and hemostasis and transfusion medicine, using Emory's comprehensive sickle cell and hemostasis/thrombosis centres.
The programme
- Focus
- Classical haematology
- Training type
- Subspecialty training programme
- Duration
- 3 years (up to 24 months of clinical or basic/translational research)
- Start
- 1 July
- Positions
- 2 fellows per year (HFFTP track)
- Accreditation
- Track within the ACGME-accredited Emory Hematology and Medical Oncology Fellowship; leads to ABIM hematology certification eligibility
- Department
- Not stated on official page
Eligibility and visa
- Eligibility
- MDs and DOs who completed training in internal medicine or medicine-paediatrics
- International applicants
- Not stated on official page
- Visa support
- Not stated on official page
- Licence requirement
- Not stated on official page
How to apply
- Deadline
- Fellows selected approximately 7–10 months before the 1 July start (for the July 2025 start, applications opened 1 July 2024)
- Application method
- ERAS
Funding
- Funding
- ASH-funded HFFTP: per fellow, ,000/year visiting rotation stipend, ,000/year ASH Annual Meeting stipend and ,500/year scholarly research stipend for three years